Judge shows reluctance to break up Google ads business in US monopoly case

Financial TimesFriday, November 21, 2025 at 10:32:38 PM
Judge shows reluctance to break up Google ads business in US monopoly case
  • Judge Leonie Brinkema has shown hesitance to order the breakup of Google's advertising business amid a US monopoly case, indicating that a forced sale could be challenging to implement.
  • This development is significant as it reflects the complexities involved in antitrust actions against major tech companies, particularly in determining the feasibility of enforcing such drastic measures.
  • The case highlights ongoing debates about the power of tech giants like Google and their critical roles in various sectors, including finance, as recognized by the EU's designation of Google as a 'critical' technology provider.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Continue Readings
Donald Trump wields dealmaking diplomacy to shape US foreign policy
NeutralFinancial Markets
President Donald Trump's latest diplomatic efforts in Ukraine focus on securing financial agreements as part of his peacemaking initiatives. This approach reflects his ongoing strategy to leverage dealmaking in shaping U.S. foreign policy.
Bill Ackman Prepares for 2026 Pershing Square IPO, FT Reports
PositiveFinancial Markets
Billionaire hedge fund manager Bill Ackman is preparing for a long-anticipated initial public offering (IPO) for his firm, Pershing Square Capital Management, according to a report by the Financial Times, which cited unnamed sources familiar with the situation.
Bill Ackman plots IPO of hedge fund Pershing Square in early 2026
PositiveFinancial Markets
Billionaire investor Bill Ackman is planning to take his hedge fund, Pershing Square, public as early as the first quarter of 2026. This move marks a significant step for Ackman, who has been a prominent figure in the investment community.
Eli Lilly becomes first pharma group to join $1tn club
PositiveFinancial Markets
Eli Lilly has become the first pharmaceutical company to achieve a market value of $1 trillion, driven by a nearly 40% surge in its shares this year. This growth is largely attributed to the strong demand for its weight-loss and diabetes medications, particularly GLP-1 drugs.
Lagarde warns European growth is linked to ‘disappearing’ world
NegativeFinancial Markets
Christine Lagarde, President of the European Central Bank, has warned that European economic growth is increasingly at risk due to a reliance on an export-dependent model that is becoming obsolete. She criticized policymakers for six years of inaction, emphasizing the urgent need for reforms to adapt to changing global dynamics.
Lawrence Summers’ extraordinary fall from grace
NegativeFinancial Markets
Lawrence Summers, a prominent American economist and former Treasury Secretary, is facing significant reputational damage following the revelation of emails exchanged with Jeffrey Epstein. The correspondence has raised concerns about Summers' judgment and associations, leading to widespread criticism and scrutiny.
The bear case for 2026
NeutralFinancial Markets
The article discusses the potential bearish outlook for the markets in 2026, highlighting concerns over economic indicators and market trends. It also references a recent jobs report, which may influence investor sentiment and economic policy decisions moving forward.
Davos assured Trump ‘woke’ topics were off the agenda
NeutralFinancial Markets
US officials informed the organizers of the Davos meeting that President Trump's participation in January would depend on the agenda, specifically requesting that 'woke' topics be excluded from discussions. This indicates the administration's desire to steer clear of contentious social issues during the event.